1. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Issue 8 (August 2018) Authors: Llanos-Cuentas, Alejandro; Casapia, Martin; Chuquiyauri, Raúl; Hinojosa, Juan-Carlos; Kerr, Nicola; Rosario, Maria; Toovey, Stephen; Arch, Robert H; Phillips, Margaret A; Rozenberg, Felix D; Bath, Jade; Ng, Caroline L; Cowell, Annie N; Winzeler, Elizabeth A; Fidock, David A; Baker, Mark; Möhrle, ... Journal: Lancet infectious diseases Issue: Volume 18:Issue 8(2018) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗